2007
DOI: 10.1177/1358863x07084858
|View full text |Cite
|
Sign up to set email alerts
|

Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease

Abstract: Intermittent claudication (IC) is the major clinical manifestation of peripheral arterial disease (PAD). Apoptosis has been linked to skeletal muscle pathophysiology in other chronic diseases such as congestive heart failure. This study tested the hypothesis that there would be increased levels of apoptosis in the skeletal muscle of patients with PAD compared with control individuals. In total, 26 individuals with PAD and 28 age-appropriate controls underwent studies of peak oxygen consumption (peak VO 2 ) and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
47
0
2

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 61 publications
(51 citation statements)
references
References 19 publications
2
47
0
2
Order By: Relevance
“…[122][123][124][125] These structural changes may be mediated, in part, by higher levels of inflammatory mediators in PAD. 126 On the basis of biopsy specimens from the gastrocnemius muscles of patients with PAD, ≈4% of gastrocnemius cells are apoptotic, and caspase-3 levels are twice as high as in patients without PAD.…”
Section: Skeletal Muscle Structural Abnormalitiesmentioning
confidence: 99%
See 1 more Smart Citation
“…[122][123][124][125] These structural changes may be mediated, in part, by higher levels of inflammatory mediators in PAD. 126 On the basis of biopsy specimens from the gastrocnemius muscles of patients with PAD, ≈4% of gastrocnemius cells are apoptotic, and caspase-3 levels are twice as high as in patients without PAD.…”
Section: Skeletal Muscle Structural Abnormalitiesmentioning
confidence: 99%
“…126 On the basis of biopsy specimens from the gastrocnemius muscles of patients with PAD, ≈4% of gastrocnemius cells are apoptotic, and caspase-3 levels are twice as high as in patients without PAD. 125 Selective fiber type switching from type I (aerobic) to type II (glycolytic) fibers may impair skeletal muscle performance and has been associated with decreased exercise tolerance. 123 Decreased expression of myosin heavy-chain isoform II in patients with PAD may also result in altered muscle contraction kinetics and decreased cellular efficiency.…”
Section: Skeletal Muscle Structural Abnormalitiesmentioning
confidence: 99%
“…12,17,18 Another important factor in patients with PVI is the presence of pain in areas distal to damage caused by ischemia provoked by the pathology itself 19 and, as a result, these patients tend to have lower physical activity levels and impaired walking capacity, all of which results in a general process of loss of fitness, inactivity and worsened quality-of-life. 20 Arterial damage may be exacerbated by the abnormal hemodynamic response, chronic venous insufficiency or heart failure; it was notable that patients with PVI achieved shorter distances in the 6MWT than patients with HF alone.…”
Section: Discussionmentioning
confidence: 99%
“…23 In PAD patients' calf muscles, increased muscle cell apoptosis and decreased capillary density are noted at the cellular and tissue levels, and muscle energetics are associated with mitochondrial dysfunction. 34, 35 Bauer et al reported that mitochondrial dysfunction may affect the muscle oxygen utilization rate and accelerate endothelial cell damage. 36, 37 We consider that our SW therapy may contribute, at least in part, to an improvement in mitochondrial dysfunction and muscle oxygen utilization.…”
Section: Study Limitationsmentioning
confidence: 99%